Trial Profile
Extreme Study
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 11 Jul 2019
Price :
$35
*
At a glance
- Drugs Oxycodone/naltrexone (Primary)
- Indications Pain
- Focus Registrational; Therapeutic Use
- Sponsors Cassava Sciences
- 20 Dec 2006 New trial record.